Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
03/05/1998 | CA2263885A1 Compounds and methods for treatment and diagnosis of mycobacterial infections |
03/05/1998 | CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use |
03/05/1998 | CA2263819A1 Insecticidal protein toxins from photorhabdus |
03/05/1998 | CA2259151A1 Enzyme and dna sequence encoding same |
03/04/1998 | EP0826775A1 Vector system for conditional gene expression |
03/04/1998 | EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase |
03/04/1998 | EP0826695A1 Destruction of contaminating tumor cells in stem cell transplants by use of bispecific antibodies |
03/04/1998 | EP0826367A2 Use of an extract of Bertholletia in cosmetics or in pharmaceuticals, and for the preparation of cell-culture media |
03/04/1998 | EP0826062A1 Hbv vectors and cells for producing the same |
03/04/1998 | EP0826056A2 Stable variant hk2 polypeptide |
03/04/1998 | EP0826048A1 Pancreas-derived serpin |
03/04/1998 | EP0826045A1 Nucleic acids for treating obesity |
03/04/1998 | EP0826044A1 Bmp-15 compositions |
03/04/1998 | EP0826043A1 Methods for modulating t cell survival by modulating bcl-x l? protein level |
03/04/1998 | EP0826042A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
03/04/1998 | EP0826041A1 Transforming growth factor alpha hii |
03/04/1998 | EP0826035A1 Isolating and culturing schwann cells |
03/04/1998 | EP0826034A1 Generation of large genomic dna deletions |
03/04/1998 | EP0826033A1 Ataxia-telangiectasia gene |
03/04/1998 | EP0825996A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
03/04/1998 | EP0825873A2 Anticancer vaccine comprising il6/il6 receptor transfected cells |
03/04/1998 | EP0656121B1 Method for diagnosing and monitoring sepsis |
03/04/1998 | EP0554389B1 Molecular clones of hiv-1 and uses thereof |
03/04/1998 | CN1175263A Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
03/03/1998 | US5723762 Transgenic plants expressing a prokaryotic ammonium dependent asparagine synthetase |
03/03/1998 | US5723761 Plant acyl-ACP thioesterase sequences |
03/03/1998 | US5723760 Genetic engineering |
03/03/1998 | US5723759 Pyrrolnitrin biosynthesis genes |
03/03/1998 | US5723756 Genetic engineering |
03/03/1998 | US5723754 Tapetum-specific promoters from Brassicaceae spp |
03/03/1998 | US5723751 Expression motifs that confer tissue and development-specific expression in plants |
03/03/1998 | US5723747 Wax esters in transformed plants |
03/03/1998 | US5723746 Reduced ethylene synthesis and delayed fruit ripening in transgenic tomatoes expressing S-adenosylmethionine hydrolase |
03/03/1998 | US5723738 Soybean cultivar 916119311654 |
03/03/1998 | US5723588 Heat stable resin with polypeptides such as elastin, collagen with keratin or silk proteins |
03/03/1998 | US5723585 Method of purifying cardiac hypertrophy factor |
03/03/1998 | US5723583 Antibody containing sialyl lewis X determinants |
03/03/1998 | US5723582 Immunology and autoimmune diseases |
03/03/1998 | US5723440 Insecticides and pesticides |
03/03/1998 | US5723437 Glycoproteins and cell surfaces and scavenger receptors |
03/03/1998 | US5723343 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
03/03/1998 | US5723333 Vectors of oncogenes, promoters, transcription |
03/03/1998 | US5723331 Methods and compositions for the repair of articular cartilage defects in mammals |
03/03/1998 | US5723329 DNA encoding retinoid receptor X (RXR) alpha and gamma; corresponding vectors and host cells |
03/03/1998 | US5723324 Apparatus and method for electrostatic endothelial cell seeding and DNA transfection in a vascular prosthesis |
03/03/1998 | US5723319 Cultured cell line that inducibly expresses the hepatitis B virus genome, and uses thereof for screening antiviral substances |
03/03/1998 | US5723316 α-1-antichymotrypsin analogues having chymase inhibiting activity |
03/03/1998 | US5723315 Secreted proteins and polynucleotides encoding them |
03/03/1998 | US5723314 Antigens and antibodies and peptides |
03/03/1998 | US5723313 ARF-p19, a novel regulator of the mammalian cell cycle |
03/03/1998 | US5723306 Monoclonal antibodies for the detection of pyrethroids and a process for their production |
03/03/1998 | US5723299 Somatostatin receptors |
03/03/1998 | US5723291 Methods for screening compounds for estrogenic activity |
03/03/1998 | US5723125 Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
02/26/1998 | WO1998008089A1 Identification of activators and inhibitors of sebum formation |
02/26/1998 | WO1998007876A2 Self-replicating episomal expression vectors conferring tissue-specific gene expression |
02/26/1998 | WO1998007872A1 Homocysteine desulphurase from the protozoan trichomonas vaginalis |
02/26/1998 | WO1998007865A1 Targeting adenovirus with use of constrained peptide motifs |
02/26/1998 | WO1998007864A1 Recombinant toxin fragments |
02/26/1998 | WO1998007859A2 Secreted proteins and polynucleotides encoding them |
02/26/1998 | WO1998007857A1 Reagents and methods useful for detecting diseases of the breast |
02/26/1998 | WO1998007855A2 Secreted proteins and polynucleotides encoding them |
02/26/1998 | WO1998007854A1 Human glycine transporter |
02/26/1998 | WO1998007853A1 Secreted proteins and polynucleotides encoding them |
02/26/1998 | WO1998007841A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
02/26/1998 | WO1998007840A1 Novel dnas and process for producing proteins by using the same |
02/26/1998 | WO1998007837A1 Improved nucleic acids for reducing carbohydrate epitopes |
02/26/1998 | WO1998007833A1 Compositions and methods for use of defensin |
02/26/1998 | WO1998007832A1 Recombinant vascular endothelial cell growth factor d (vegf-d) |
02/26/1998 | WO1998007829A8 Use of flexible plastic tanks in gene theraphy |
02/26/1998 | WO1998007829A2 Use of flexible plastic tanks in gene theraphy |
02/26/1998 | WO1998007828A1 Device with a reaction bag for multi-step culturing/separation operations and/or reactions in several steps |
02/26/1998 | WO1998007754A1 T1 receptor-like ligand ii |
02/26/1998 | WO1998007747A1 Transformed wheat having improved breadmaking characteristics |
02/26/1998 | WO1998007737A1 Method for determining expression of aberrant forms of apc protein |
02/26/1998 | WO1998007736A1 Don-1 gene and polypeptides and uses therefor |
02/26/1998 | WO1997046681A3 Galanin receptor galr2 |
02/26/1998 | DE19648962C1 DNA encoding peptide(s) from papilloma virus major capsid protein |
02/26/1998 | DE19633731A1 Hybrid cells used as anti-cancer vaccine |
02/26/1998 | CA2264952A1 Improved nucleic acids for reducing carbohydrate epitopes |
02/26/1998 | CA2264271A1 Transformed wheat having improved breadmaking characteristics |
02/26/1998 | CA2264206A1 Device with a reaction bag for multi-step culturing/separation operations and/or reactions in several steps |
02/26/1998 | CA2264205A1 Use of flexible plastic tanks in gene therapy |
02/26/1998 | CA2264203A1 Compositions and methods for use of defensin |
02/26/1998 | CA2264192A1 Secreted proteins and polynucleotides encoding them |
02/26/1998 | CA2264054A1 Method for determining expression of aberrant forms of apc protein |
02/26/1998 | CA2263894A1 Novel human growth factors |
02/26/1998 | CA2263890A1 Recombinant vascular endothelial cell growth factor d (vegf-d) |
02/26/1998 | CA2263875A1 Secreted proteins and polynucleotides encoding them |
02/26/1998 | CA2263854A1 Don-1 gene and polypeptides and uses therefor |
02/26/1998 | CA2263832A1 T1 receptor-like ligand ii |
02/26/1998 | CA2263796A1 Self-replicating episomal expression vectors conferring tissue-specific gene expression |
02/26/1998 | CA2263192A1 Secreted proteins and polynucleotides encoding them |
02/26/1998 | CA2263140A1 Targeting adenovirus with use of constrained peptide motifs |
02/26/1998 | CA2262817A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
02/26/1998 | CA2235148A1 Novel dnas and process for producing proteins by using the same |
02/25/1998 | EP0825260A2 Arginase II |
02/25/1998 | EP0825256A2 Hybrid cell and its use for the preparation of a drug for the induction of tumourimmunity |
02/25/1998 | EP0825255A1 Method of producing activated killer monocytes |
02/25/1998 | EP0824594A1 Improved methods for transfecting t cells |